Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells

Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells
Human brain cancer cells cultured on the DN gel expressed a stem cell marker protein SOX 2 (green). Credit: Jun Suzuka et al., Nature Biomedical Engineering, March 29, 2021

A hydrogel developed at Hokkaido University successfully reverted cancer cells back to cancer stem cells within 24 hours in six different human cancer types. This could lead to the development of anti-cancer stem cell drugs and personalized medicines.

Cancer is the leading cause of death in developed countries, and more than 8.6 million people die from annually worldwide. Despite the advancement of treatments, the five-year survival rate of patients with advanced-stage cancer remains low. One reason is that cancer tissues contain cancer stem cells, which are resistant to chemotherapies and radiotherapies. These cells can hide as "roots" or circulate in the body, causing cancer recurrence.

"Cancer stem cells are a major target for , but they are difficult to identify because they are present in very small numbers in cancer tissues," explained Professor Shinya Tanaka of Hokkaido University's Faculty of Medicine. "Understanding the of cancer stem cells is crucial for developing better cancer treatments."

Cancer stem cells require a very specific microenvironment. In this study, the research team investigated whether their DN gel could recreate the right conditions to induce cancer stem cells. The DN gel consists of a network of two chemicals and incorporates a high volume of water, giving it soft and wet characteristics resembling biological tissues.

Human brain cancer cells forming spherical structures on the DN gel. Credit: Jun Suzuka et al., Nature Biomedical Engineering, March 29, 2021

In the study, the DN gel rapidly reprogrammed differentiated cancer cells into cancer stem cells in just 24 hours in six different human cancer cell lines—, , lung cancer, colon cancer, bladder cancer and sarcoma. After cancer cells were placed on the DN gel, they started to form spherical structures and produce specific molecules known to be markers of cancer stem cells such as SOX2 and Oct3/4, aka Yamanaka factors, named after the Nobel Prize laureate, suggesting they had been reprogrammed.

The researchers also uncovered some of the molecular mechanisms involved in cancer cell reprogramming. They found that calcium channel receptors and the protein osteopontin were essential for the induction of cancer stem cells. They also found that brain cancer cells from a patient that had been cultured on the DN gel produced receptors called platelet-derived growth factor receptors. By adding a molecular inhibitor of these receptors, they were able to target and eradicate the cancer stem cells, suggesting that the DN gel could be used to select therapeutic drugs. In addition, they showed that the brain cancer that had been cultured on DN gel formed tumors efficiently when transplanted into mice brain, suggesting the stemness of the .

Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells
The cancer stem cells cultured on the DN gel formed a tumor when injected into mice brain. Credit: Jun Suzuka et al., Nature Biomedical Engineering, March 29, 2021

This study paves the way for research into drugs that can target . "In the future, the DN gel could be used to enhance cancer cell type diagnosis and to produce personalized medicines, which could improve the prognosis of cancer patients," said Shinya Tanaka.


Explore further

Drug target for aggressive breast cancer found

More information: Rapid reprogramming of tumor cells into cancer stem cells on double-network hydrogels, Nature Biomedical Engineering (2021). DOI: 10.1038/s41551-021-00692-2
Citation: Uprooting cancer: Hydrogel rapidly reverts cancer cells back to cancer stem cells (2021, March 29) retrieved 10 August 2022 from https://medicalxpress.com/news/2021-03-uprooting-cancer-hydrogel-rapidly-reverts.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
412 shares

Feedback to editors